1. Clinical & Scientific Overview
Primaquine Phosphate (TIP-MED-000342, Reference Code [8.29]-C72) is classified under
Antimicrobials — Antimalarial & Anthelmintic Agents (Ch 08) as a 4-Aminoquinoline Blood Schizonticide & 8-Aminoquinoline Hypnozoitocide/Gametocytocide Antimalarials (Schedule H | NLEM 2022).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Co-indexed constituent under primary monograph [8.29] (Chloroquine Phosphate & Primaquine Phosphate). Representative Indian Market Examples (Edition 2.7 Ch 08 [8.29], p. 107): Chloroquine: Lariago (Ipca), Resochin (Bayer), Emquin (Merck). Primaquine: Malirid (Ipca), Leoprime — Strengths & Dosage Forms: Chloroquine Tablets: 250 mg Chloroquine Phosphate (= 150 mg Chloroquine Base!), 500 mg DS (= 300 mg Base); Syrup: 50 mg Base/5mL. Primaquine Tablets: 2.5 mg, 7.5 mg, 15 mg Base
Chloroquine Tablets: 250 mg Chloroquine Phosphate (= 150 mg Chloroquine Base!), 500 mg DS (= 300 mg Base); Syrup: 50 mg Base/5mL. Primaquine Tablets: 2.5 mg, 7.5 mg, 15 mg Base
3. Mechanism of Action & Pharmacodynamics
4-Aminoquinoline Blood Schizonticide & 8-Aminoquinoline Hypnozoitocide/Gametocytocide Antimalarials (Schedule H | NLEM 2022) acting on target receptor/enzyme pathways in Antimicrobials — Antimalarial & Anthelmintic Agents (Ch 08): clinical efficacy is mediated via 4-Aminoquinoline Blood Schizonticide & 8-Aminoquinoline Hypnozoitocide/Gametocytocide Antimalarials (Schedule H | NLEM 2022) for Uncomplicated Plasmodium vivax malaria across India (NVBDCP Regimen: 3-day Chloroquine + 14-day Primaquine radical cure to eradicate dormant hepatic hypnozoites); Primaquine single 0.75 mg/kg dose on Day 2 of ACT to block P. falciparum transmission.
4. Therapeutic Indications & Evidence-Supported Uses
- Uncomplicated Plasmodium vivax malaria across India (NVBDCP Regimen: 3-day Chloroquine + 14-day Primaquine radical cure to eradicate dormant hepatic hypnozoites)
- Primaquine single 0
- 75 mg/kg dose on Day 2 of ACT to block P
- falciparum transmission
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: NVBDCP P. VIVAX ADULT REGIMEN (60 kg): Chloroquine: Day 1: 10 mg base/kg (4 tabs of 250 mg [600 mg base]); Day 2: 10 mg base/kg (4 tabs [600 mg base]); Day 3: 5 mg base/kg (2 tabs [300 mg base]) — Total 10 tablets over 3 days + Primaquine: 0.25 mg/kg/day (15 mg PO OD) for 14 DAYS!
Administration & Meal Timing: MUST take both Chloroquine and Primaquine immediately AFTER a full meal or milk (taking fasting causes severe vomiting, hypotension, and epigastric cramps!) | Chloroquine: Days 1, 2, & 3 after food. Primaquine: Once Daily after breakfast for 14 days
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Follows class pharmacokinetic profile detailed in parent monograph [8.29].
Renal: No adjustment needed for a 3-day acute malaria course. Hepatic: Caution in severe liver disease
Renal: No adjustment needed for a 3-day acute malaria course. Hepatic: Caution in severe liver disease
Renal: No adjustment needed for a 3-day acute malaria course. Hepatic: Caution in severe liver disease
7. Contraindications, Precautions & High-Risk Warnings
- CRITICAL G6PD DEFICIENCY & PREGNANCY CONTRAINDICATIONS FOR PRIMAQUINE: Primaquine is STRICTLY CONTRAINDICATED in (1) Severe G6PD Deficiency (causes massive fatal intravascular haemolysis — test G6PD before starting 14-day Primaquine!), (2) PREGNANCY & Breastfeeding of infants <6 months, and (3) Infants <6 months! (Chloroquine 3-day regimen IS safe in all trimesters of pregnancy!)
Key Clinical Precautions: Renal: No adjustment needed for a 3-day acute malaria course. Hepatic: Caution in severe liver disease
8. Adverse Effects Profile
- Chloroquine: Intense generalised pruritus (treat with antihistamine/calamine, not an allergy!), nausea, bitter taste, headache. Primaquine: Epigastric pain, mild methaemoglobinaemia
- Primaquine: Acute massive intravascular haemolysis in G6PD deficiency (dark Coca-Cola/black urine, rapid jaundice, pallor, oliguria!). Chloroquine: QTc prolongation, arrhythmias, hypoglycaemia, seizures; narrow therapeutic index in paediatric overdose
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Additive QTc prolongation with Amiodarone, Ondansetron, Domperidone, Macrolides, and Fluoroquinolones; Antacids/Kaolin reduce Chloroquine absorption (space by >=4h); Chloroquine increases Digoxin and Cyclosporine levels
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [8.29].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: THREE VITAL MALARIA COUNTER RULES: (1) Always take Lariago and Malirid on a full stomach after food; (2) Complete all 14 days of Malirid (Primaquine) even after fever is gone, otherwise vivax malaria will relapse; (3) STOP Malirid immediately and go to hospital if your urine turns dark brown/black or your eyes turn yellow; never give Malirid in pregnancy
- Meal & Clock Timing Instruction: MUST take both Chloroquine and Primaquine immediately AFTER a full meal or milk (taking fasting causes severe vomiting, hypotension, and epigastric cramps!) (Chloroquine: Days 1, 2, & 3 after food. Primaquine: Once Daily after breakfast for 14 days)
- Missed Dose Protocol: If vomiting occurs within 30 minutes of Chloroquine dose, repeat the full dose; if within 30–60 minutes, repeat half the dose
- Geriatric Dispensing Pearl: Screen ECG/QTc and interacting drugs before dispensing Chloroquine to older adults
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Chloroquine Tablets: 250 mg Chloroquine Phosphate (= 150 mg Chloroquine Base!), 500 mg DS (= 300 mg Base); Syrup: 50 mg Base/5mL. Primaquine Tablets: 2.5 mg, 7.5 mg, 15 mg Base
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [8.32]-C75 Diethylcarbamazine Citrate (DEC) — Avermectin Glutamate-Gated Chloride Channel Agonist & Piperazine
- [8.29] Chloroquine Phosphate & Primaquine Phosphate — 4-Aminoquinoline Blood Schizonticide & 8-Aminoquinoline Hypnozoit
- [8.30] Artemether + Lumefantrine & Artesunate — Artemisinin-Based Combination Therapy (ACT-AL) & Parenteral Sever
- [8.31] Albendazole & Mebendazole — Benzimidazole Beta-Tubulin Polymerisation Inhibitor Anthelmintics